JF
VOR icon

Jump Financial’s Vor Biopharma VOR Stock Holding History

Jump Financial’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Sell
70,889
-102,139
-59% -$1.55M 0.01% 1062
2026
Q1 		$3.09M Buy
+173,028
New +$2.44M 0.04% 489
2024
Q3 		– Sell
-566
Closed -$11.3K – 2159
2024
Q2 		$11.3K Buy
+566
New +$18.3K ﹤0.01% 1726
2023
Q3 		– Sell
-930
Closed -$57.5K – 2285
2023
Q2 		$57.5K Buy
930
+414
+80% +$37.8K ﹤0.01% 1719
2023
Q1 		$55.6K Buy
+516
New +$57.2K ﹤0.01% 1492

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Jump Financial's VOR Position: Q2 2026 in Review

Jump Financial reduced its Vor Biopharma (VOR) stake by 59% in Q2 2026, selling an estimated $1.55M and leaving 70,889 shares worth $1.31M. The position accounts for 0.01% of the portfolio, ranked #1062.

Jump Financial first reported a position in VOR in Q1 2023 and has held it in 5 quarters since. The position peaked at $3.09M in Q1 2026. 102 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • Jump Financial held 70,889 shares of Vor Biopharma worth $1.31M as of Q2 2026.
  • Jump Financial sold 102,139 Vor Biopharma shares in Q2 2026, an estimated $1.55M.
  • Vor Biopharma made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1062 holding.
  • Jump Financial first reported a position in Vor Biopharma in Q1 2023 and has held it in 5 quarters since.
  • Jump Financial's Vor Biopharma position peaked at $3.09M in Q1 2026.
  • 102 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.